Silver X expands Nueva Recuperada plant toward 1,000 tpd capacity in 4Q26
Bitget2026/10/08 11:47Silver X reported 3Q26 production results as it advanced a Nueva Recuperada plant expansion to 1,000 tonnes per day. Plant throughput averaged 594 tpd during expansion work; processed tonnage rose 63% year over year to 54,681 metric tons. AgEq processed increased 42% to 322,822 oz; AgEq produced rose 35% to 225,237 oz. Gold ounces processed climbed 119% to 1,641 oz on higher throughput; gold head grades averaged 0.93 g/t. Ore mined rose 113% to 60,694 metric tons; a roughly 6,000-ton stockpile was built ahead of a planned 4Q26 step-up. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silver X Mining Corp. published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.
- Silver X reported 3Q26 production results as it advanced a Nueva Recuperada plant expansion to 1,000 tonnes per day.
- Plant throughput averaged 594 tpd during expansion work; processed tonnage rose 63% year over year to 54,681 metric tons.
- AgEq processed increased 42% to 322,822 oz; AgEq produced rose 35% to 225,237 oz.
- Gold ounces processed climbed 119% to 1,641 oz on higher throughput; gold head grades averaged 0.93 g/t.
- Ore mined rose 113% to 60,694 metric tons; a roughly 6,000-ton stockpile was built ahead of a planned 4Q26 step-up.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
